Skip to content
Home/Companies/MedTech/Perfectus Biomed Group

Perfectus Biomed Group

MedTech·UK·Exited 2022·Held 9yr
Entry
2013
Hold
9yr
Exit
2022

Who owns Perfectus Biomed Group?

Perfectus Biomed Group is a British MedTech company, now owned by NAMSA, which acquired it in 2022 from River Capital.

Hand-verified · updated 2026-06-30

Open JSON · CC-BY
River Capital
Investor
River Capital
NW Fund for Biomedical · 2010 · Healthcare

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
NAMSA
Exit Year
2022

More from NW Fund for Biomedical

Other portfolio companies in the same fund.

Alderley Analytical
4.0xExited 2024
HealthcareUK· 2015
to Synexa Life Sciences

More River Capital portfolio companies

From the same investor, across funds.

Deltabase
Deltabase
Active
AI/MLUK· 2026
Infinium Group
Infinium Group
Active
TMTUK· 2026
urfuture
urfuture
Active
HR TechUK· 2026
Fotenix
Active
AgTechUK· 2025
HyperFinity
Active
Data & AnalyticsUK· 2025
Mojo-CX
Active
SaaSUK· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Perfectus Biomed Group?

Perfectus Biomed Group is now owned by NAMSA, which acquired it in 2022 from River Capital.

When did NAMSA acquire Perfectus Biomed Group?

NAMSA acquired Perfectus Biomed Group in 2022, buying from River Capital.

Who did Perfectus Biomed Group sell to?

River Capital sold Perfectus Biomed Group to NAMSA in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue